A Comprehensive Study of the Retinal Phenotype of Rpe65-Deficient Dogs

被引:6
|
作者
Annear, Matthew J. [1 ]
Mowat, Freya M. [1 ,6 ,7 ]
Occelli, Laurence M. [1 ]
Smith, Alexander J. [2 ]
Curran, Paul G. [3 ]
Bainbridge, James W. [2 ,4 ,5 ]
Ali, Robin R. [2 ,4 ,5 ]
Petersen-Jones, Simon M. [1 ]
机构
[1] Michigan State Univ, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA
[2] UCL Inst Ophthalmol, Dept Genet, 11-43 Bath St, London EC1V 9EL, England
[3] Michigan State Univ, Ctr Stat Consulting, E Lansing, MI 48824 USA
[4] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, City Rd, London EC1V 2PD, England
[5] UCL Inst Ophthalmol, City Rd, London EC1V 2PD, England
[6] Univ Wisconsin Maddison, Dept Ophthalmol & Visual Sci, Maddison, WI 53706 USA
[7] Univ Wisconsin Maddison, Dept Surg Sci, Maddison, WI 53706 USA
关键词
Rpe65; canine; Leber congenital amaurosis; large animal model; ERG; OCT; retinal degeneration;
D O I
10.3390/cells10010115
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The Rpe65-deficient dog has been important for development of translational therapies of Leber congenital amaurosis type 2 (LCA2). The purpose of this study was to provide a comprehensive report of the natural history of retinal changes in this dog model. Rpe65-deficient dogs from 2 months to 10 years of age were assessed by fundus imaging, electroretinography (ERG) and vision testing (VT). Changes in retinal layer thickness were assessed by optical coherence tomography and on plastic retinal sections. ERG showed marked loss of retinal sensitivity, with amplitudes declining with age. Retinal thinning initially developed in the area centralis, with a slower thinning of the outer retina in other areas starting with the inferior retina. VT showed that dogs of all ages performed well in bright light, while at lower light levels they were blind. Retinal pigment epithelial (RPE) inclusions developed and in younger dogs and increased in size with age. The loss of photoreceptors was mirrored by a decline in ERG amplitudes. The slow degeneration meant that sufficient photoreceptors, albeit very desensitized, remained to allow for residual bright light vision in older dogs. This study shows the natural history of the Rpe65-deficient dog model of LCA2.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 50 条
  • [1] Gene therapy in the second eye of RPE65-deficient dogs improves retinal function
    M J Annear
    J T Bartoe
    S E Barker
    A J Smith
    P G Curran
    J W Bainbridge
    R R Ali
    S M Petersen-Jones
    Gene Therapy, 2011, 18 : 53 - 61
  • [2] Gene therapy in the second eye of RPE65-deficient dogs improves retinal function
    Annear, M. J.
    Bartoe, J. T.
    Barker, S. E.
    Smith, A. J.
    Curran, P. G.
    Bainbridge, J. W.
    Ali, R. R.
    Petersen-Jones, S. M.
    GENE THERAPY, 2011, 18 (01) : 53 - 61
  • [3] RPE65 gene therapy slows cone loss in Rpe65-deficient dogs
    Mowat, F. M.
    Breuwer, A. R.
    Bartoe, J. T.
    Annear, M. J.
    Zhang, Z.
    Smith, A. J.
    Bainbridge, J. W. B.
    Petersen-Jones, S. M.
    Ali, R. R.
    GENE THERAPY, 2013, 20 (05) : 545 - 555
  • [4] RPE65 gene therapy slows cone loss in Rpe65-deficient dogs
    F M Mowat
    A R Breuwer
    J T Bartoe
    M J Annear
    Z Zhang
    A J Smith
    J W B Bainbridge
    S M Petersen-Jones
    R R Ali
    Gene Therapy, 2013, 20 : 545 - 555
  • [5] Early-Onset Progressive Degeneration of the Area Centralis in RPE65-Deficient Dogs
    Mowat, Freya M.
    Gervais, Kristen J.
    Occelli, Laurence M.
    Annear, Matthew J.
    Querubin, Janice
    Bainbridge, James W.
    Smith, Alexander J.
    Ali, Robin R.
    Petersen-Jones, Simon M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (07) : 3268 - 3277
  • [6] Regulation of Retinal Function but Nonrescue of Vision in RPE65-deficient Dogs Treated With Doxycycline-regulatable AAV Vectors
    Lheriteau, Elsa
    Libeau, Lyse
    Mendes-Madeira, Alexandra
    Deschamps, Jack-Yves
    Weber, Michel
    Le Meur, Guylene
    Provost, Nathalie
    Guihal, Caroline
    Moullier, Philippe
    Rolling, Fabienne
    MOLECULAR THERAPY, 2010, 18 (06) : 1085 - 1093
  • [7] Results at 5 Years After Gene Therapy for RPE65-Deficient Retinal Dystrophy
    Pennesi, Mark E.
    Weleber, Richard G.
    Yang, Paul
    Whitebirch, Chris
    Thean, Beverly
    Flotte, Terence R.
    Humphries, Margaret
    Chegarnov, Elvira
    Beasley, Kathleen N.
    Stout, J. Timothy
    Chulay, Jeffrey D.
    HUMAN GENE THERAPY, 2018, 29 (12) : 1428 - 1437
  • [8] Expression of opsin and IRBP in the Rpe65-deficient mouse
    Redmond, TM
    McLemore, P
    Yu, S
    Gentleman, S
    Ma, JX
    Crouch, RK
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S391 - S391
  • [9] Retinal Disease in Rpe65-Deficient Mice: Comparison to Human Leber Congenital Amaurosis Due to RPE65 Mutations
    Caruso, Rafael C.
    Aleman, Tomas S.
    Cideciyan, Artur V.
    Roman, Alejandro J.
    Sumaroka, Alexander
    Mullins, Cristina L.
    Boye, Sanford L.
    Hauswirth, William W.
    Jacobson, Samuel G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (10) : 5304 - 5313
  • [10] Regulation of Retinal Function but Non Rescue of Vision in Rpe65-Deficient Dogs Treated With Doxycycline-Regulatable Aav Vectors
    Lheriteau, E.
    Libeau, L.
    Mendes-Madeira, A.
    Deschamps, J. -Y.
    Weber, M.
    Le Meur, G.
    Provost, N.
    Guihal, C.
    Moullier, P.
    Rolling, F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)